YKST02 / Excyte - LARVOL DELTA

Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - P2 | N=64 | Not yet recruiting | Sponsor: Excyte Biopharma Ltd

New P2 trial • Hematological Malignancies • Multiple Myeloma • Oncology

A Study of YKST02 in Participants With Primary IgA Nephropathy (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Not yet recruiting ➔ Recruiting

Enrollment open • Glomerulonephritis • IgA Nephropathy • Renal Disease

A Study of YKST02 in Participants With Primary IgA Nephropathy (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

New P1 trial • Glomerulonephritis • IgA Nephropathy • Renal Disease

Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus (clinicaltrials.gov) - P1 | N=30 | Not yet recruiting | Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Monotherapy • New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus

A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma (clinicaltrials.gov) - P1 | N=70 | Recruiting | Sponsor: Excyte Biopharma Ltd

New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology